The results of the preparation of various 2-substituted
indole-3-acetic acid derivatives are summarized in Table 1.
Table 1. Preparation of Substituted Indoles from
2-Aminocinnamates
indole
R1
R2
OEt
OEt
OEt
OEt
OEt
On-Bu
On-Bu
On-Bu
N(CH2)5
N(CH2)5
N(CH2)5
N(n-Hex)2
R3
2-naph-
3,4-(MeO)2-C6H3-
4-Ph-C6H4-
3-MeO-C6H4-
4-Pyr-
4-Cl-C6H4-
3-Pyr-
3,4-(MeO)2-C6H3-
(E)-styryl-
2-thienyl-
yield (%)
Figure 1. Biologically active 2-arylindole derivatives.
5c
5d
5e
5f
5g
5h
5i
5j
5k
5l
H
H
H
H
H
F
F
F
H
H
H
H
73
56
55
65
37
64
69
59
53
51
95
73
an affinity to the gonadotropin releasing hormone (GnRH)
receptor have also been reported (see Figure 1).30
In summary, the described synthetic protocol permits the
facile preparation of a variety of 2-aryl, 2-hetaryl-, and
2-styryl-substituted indole-3-acetic acid derivatives without
the use of expensive or sensitive reagents or catalysts.31 The
products as well as the corresponding tryptamines accessible
via reduction of the amide group belong to a class of
biologically active compounds.
5m
5n
3-Pyr-
4-F-C6H4-
Acknowledgment. This work was supported by the
Deutsche Forschungsgemeinschaft. We thank H. Kolshorn
from the institute of organic chemistry for the 2D-NMR
spectroscopic measurements.
A number of 2-aryl- and 2-hetaryl-substituted indole-3-
acetamides exhibit remarkable affinities to various G-protein
coupled receptors or enzymes. For example, FGIN-1-27
(compound 5n) is a ligand of the mDRC receptor complex
(Ki ) 4.4 nM),27 and 7 is an inhibitor of farnesyl transferase
(IC50 ) 31 nM).28 Tryptamine 8, which can be obtained by
reduction of amide 5a with lithium aluminum hydride in 99%
yield, is a known antagonist of the human 5-HT2A receptor
(Ki ) 2.7 nM),29 and 2-aryltryptamines such as 9 that have
Supporting Information Available: Detailed experi-
mental procedures and spectroscopic data as well as 1H and
13C NMR spectra of all new compounds. This material is
OL061617+
(30) Lin, P.; Parikh, M.; Lo, J. L.; Yang, Y. T.; Cheng, K.; Smith, R.
G.; Fisher, M. H.; Wyvratt, M. J.; Goulet, M. T. Bioorg. Med. Chem. Lett.
2001, 11, 1077-1080.
(22) Kison, C.; Meyer, N.; Opatz, T. Angew. Chem., Int. Ed. 2005, 44,
5662-5664.
(31) Typical Procedure. Preparation of 5i. To a solution of butyl (E)-
2-amino-5-fluorocinnamate 2c (300 mg, 1.26 mmol) and pyridine-3-
carbaldehyde (162.5 mg, 1.52 mmol) in dry n-butanol (5 mL) was added
acetic acid (87 µL, 1.52 mmol), and the solution was stirred for 1 h at 60
°C under argon. Potassium cyanide (181 mg, 2.78 mmol) and acetic acid
(145 µL, 2.53 mmol) were added to the mixture, and stirring at 60 °C was
continued for 16 h. The reaction mixture was partitioned between saturated
aqueous NaHCO3 solution and dichloromethane, the organic phase was dried
over Na2SO4, and the solvent was removed in vacuo to yield a yellow oil
(588 mg). A portion of the crude Strecker product (558 mg) was dissolved
in dry n-butanol (3 mL), and after addition of potassium tert-butyl alcoholate
(142 mg, 1.26 mmol), the solution was stirred for 30 min at room
temperature under argon. The reaction mixture was partitioned between
saturated aqueous NaHCO3 solution and dichloromethane, the organic phase
was dried over Na2SO4, and the solvent was removed in vacuo to yield a
yellow oil (492 mg). A portion of the crude indole (461 mg) was purified
by flash chromatography (SiO2, eluent cyclohexane/ethyl acetate 1:1) to
afford butyl [5-fluoro-2-(3-pyridyl)-1H-indol-3yl]-acetate 5i (252 mg,
68.7%) as yellowish crystals, mp 105-107 °C.
(23) Horaguchi, T.; Hosokawa, N.; Tanemura, K.; Suzuki, T. J. Het-
erocycl. Chem. 2002, 39, 61-67.
(24) Sicker, D.; Rabe, A.; Zakrzewski, A.; Mann, G. J. Prakt. Chem.
1987, 329, 1063-1070.
(25) Merlic, C. A.; Semmelhack, M. F. J. Organomet. Chem. 1990, 391,
C23-C27.
(26) Ma, C.; Liu, X.; Li, X.; Flippen-Anderson, J.; Yu, S.; Cook, J. M.
J. Org. Chem. 2001, 66, 4525-4542.
(27) Kozikowski, A. P.; Ma, D.; Brewer, J.; Sun, S.; Costa, E.; Romeo,
E.; Guidotti, A. J. Med. Chem. 1993, 36, 2908-2920.
(28) Trotter, B. W.; Quigley, A. G.; Lumma, W. C.; Sisko, J. T.; Walsh,
E. S.; Hamann, C. S.; Robinson, R. G.; Bhimnathwala, H.; Kolodin, D. G.;
Zheng, W.; Buser, C. A.; Huber, H. E.; Lobell, R. B.; Kohl, N. E.; Williams,
T. M.; Graham, S. L.; Dinsmore, C. J. Bioorg. Med. Chem. Lett. 2001, 11,
865-869.
(29) Smith, A. L.; Stevenson, G. I.; Lewis, S.; Patel, S.; Castro, J. L.
Bioorg. Med. Chem. Lett. 2000, 10, 2693-2696.
Org. Lett., Vol. 8, No. 20, 2006
4475